Form 4: FormFactor Director Schedules Future Share Sale

FormFactor Inc. Director Thomas St. Dennis reported a planned sale of 2,000 shares of common stock on November 17, 2025, under a Rule 10b5-1 plan.

Summary

• Director Thomas St. Dennis of FormFactor Inc. reported a transaction involving the company's common stock.
• The transaction is a planned sale of 2,000 shares of common stock.
• The sale is scheduled to occur on November 17, 2025, at a price of $49.8465 per share.
• Following this planned sale, Thomas St. Dennis will beneficially own 38,957 shares directly.
• The transaction is being executed pursuant to a Rule 10b5-1(c) plan, indicating it is a pre-scheduled and non-discretionary sale.

Sentiment

Score: 5

Explanation: A neutral score as it's a pre-arranged insider sale, which is a routine event. While a sale, the 10b5-1 plan mitigates negative sentiment as it's not a reactive decision based on new information.

Negatives

• An insider, Director Thomas St. Dennis, is planning to sell 2,000 shares of common stock.
• While pre-arranged, insider sales can sometimes be perceived negatively by the market as they reduce an insider's direct equity stake in the company.

Future Outlook

The filing indicates a pre-scheduled future transaction, suggesting a planned reduction in direct equity holdings by a director as part of a long-term financial plan.

Industry Context

This is a routine insider transaction filing and does not directly relate to broader industry trends or competitors, other than reflecting an individual director's portfolio management strategy.

Stakeholder Impact

• Shareholders: May view the planned sale as a slight negative, though the 10b5-1 plan suggests it is not based on new adverse information. It represents a minor reduction in the director's direct alignment with shareholder interests.

Key Dates

Recommendation

This Form 4 reports a pre-scheduled sale of 2,000 shares by a director under a Rule 10b5-1 plan. Such transactions are routine and typically do not reflect new material information about the company's prospects. While an insider sale, its pre-arranged nature mitigates concerns about immediate negative implications. Therefore, the filing alone does not warrant a change in investment thesis, suggesting a 'hold' recommendation based solely on this information.

Keywords

FormFactor Inc., FORM, Insider Trading, Form 4, Director Sale, Thomas St. Dennis, Equity Transaction, 10b5-1 Plan